Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03897595 · ClinicalTrials.gov registry record

Assess the Mid-term Performance of the Mpact Cup in Subjects Requiring Total Hip Arthroplasty

A clinical trial of Hip Osteoarthritis, sponsored by Medacta U.

Completed
Registry status
187
Enrollment target
5
Study locations

NCT03897595: Completed study of Hip Osteoarthritis, sponsored by Medacta U.

NCT03897595 is a study of Hip Osteoarthritis that has completed, run by Medacta U. The registered enrollment target is 187 participants, below the 388-participant average among 11 other Hip Osteoarthritis trials with a reported enrollment target (52% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03897595, a study of Hip Osteoarthritis, has completed, sponsored by Medacta U.

COMPLETED
Registry status
187 participants
Enrollment target
5
Study locations

Study Summary

Monitor the performance of the Mpact cup in the treatment of patients with hip joint disease requiring a total hip replacement.

Primary Outcome

Assessment of improvement of clinical outcomes following total hip replacement surgery using the Harris Hip Scores

Conditions Studied

Interventions

  • DEVICE MPact Cup

Study Locations (5)

Colorado

  • Denver Vail Orthopedics - Parker

Idaho

  • Saint Alphonsus Medical Group - Boise

Illinois

  • Illinois Bone and Joint Institute - Libertyville

Oklahoma

  • McBride Orthopedic Hospital - Oklahoma City

Utah

  • Jordan Valley Medical Center of Orthopedics Rehabilitation and Excellence - West Jordan

Trial Details

FieldValue
Enrollment Target 187 participants
Start Date 2012-10
Est. Completion 2022-03-30
Medacta U

3 total trials

What the finished NCT03897595 record still lists

NCT03897595 is an observational study that tracks outcomes without assigning an intervention. The registered 187 participants enrollment target is mid-sized for trials with a published cap, below the 388-participant average among 11 other Hip Osteoarthritis trials with a reported enrollment target (52% lower).

The record links to 1 condition, with Hip Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which MPact Cup is the first listed.

NCT03897595 lists 5 locations in 5 states (Colorado, Idaho, Illinois).

Frequently Asked Questions

What is clinical trial NCT03897595 about?

NCT03897595 is a clinical study titled "Assess the Mid-term Performance of the Mpact Cup in Subjects Requiring Total Hip Arthroplasty". Monitor the performance of the Mpact cup in the treatment of patients with hip joint disease requiring a total hip replacement.

What is the current status of trial NCT03897595?

This trial is currently completed. The enrollment target is 187 participants. The study started on 2012-10. Estimated completion is 2022-03-30.

What conditions does trial NCT03897595 study?

This clinical trial studies the following conditions: Hip Osteoarthritis.

What interventions are being tested in trial NCT03897595?

The interventions under investigation include: MPact Cup (DEVICE).

Who is sponsoring clinical trial NCT03897595?

This trial is sponsored by Medacta U, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03897595 being conducted?

This trial has 5 study locations across Colorado, Idaho, Illinois, Oklahoma, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hip Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03897595's enrollment target sits among peer trials

187 5th of 11 higher than 7 of 11 other Hip Osteoarthritis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hip Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06153251 · 187 participants · Phase 1

    A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

  • NCT06254898 · 187 participants · NA

    Use of Incentives for Stressful Medical Procedures

  • NCT07062237 · 187 participants · NA

    A Randomized Clinical Trial Comparing Embryo Euploidy Rates Following Ultrashort Versus Standard Abstinence

  • NCT07217574 · 187 participants

    Program in Oncology for Tribal Health Systems.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03897595, the US trial registry maintained by the National Library of Medicine. NCT03897595 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.